Evaluation of visible hematuria

Last reviewed: 22 Nov 2024
Last updated: 25 Jun 2024

Summary

Differentials

Common

  • Benign prostatic hyperplasia (BPH)
  • Urinary tract infection (UTI)
  • Acute pyelonephritis
  • Bladder cancer
  • Prostate cancer
  • Kidney stone
  • Instrumentation of the urinary tract
  • Menstruation
Full details

Uncommon

  • Renal trauma
  • Bladder trauma
  • Urethral trauma
  • Sickle cell anemia
  • Coagulopathy
  • Cystic renal disease
  • Arteriovenous malformation
  • Renal vein thrombosis
  • Alport syndrome
  • Extrapulmonary tuberculosis
  • Benign familial hematuria (thin basement membrane nephropathy)
  • Postinfectious glomerulonephritis
  • Membranoproliferative glomerulonephritis
  • Rapidly progressive glomerulonephritis
  • IgA nephropathy
  • Systemic lupus erythematosus (SLE)
  • Renal cancer
  • Metastatic cancer
  • Urethral cancer
  • Penile cancer
  • Placenta percreta
  • Endometriosis
  • Bladder stone
  • Radiation cystitis
  • Nephrotoxic/cytotoxic medications
  • Anticoagulation
  • Exercise-induced hematuria
  • Loin pain hematuria syndrome
  • Medication
  • Food-related
Full details

Contributors

Authors

Simon Y. Kimm, MD
Simon Y. Kimm

Clinical Fellow and Instructor

Division of Urologic Oncology

Memorial Sloan-Kettering Cancer Center

New York

NY

Disclosures

SYK declares that he has no competing interests.

Jeffrey H. Reese, MD
Jeffrey H. Reese

Department of Urology

Santa Clara Valley Medical Center

San Jose

Clinical Professor of Urology

Stanford University School of Medicine

Stanford

CA

Disclosures

JHR declares that he has no competing interests.

Peer reviewers

Lynda Frassetto, MD

Associate Professor of Medicine

Division of Nephrology

University of California at San Francisco

CA

Disclosures

LF declares that she has no competing interests.

Michael Fischer, MD

Assistant Professor of Medicine

University of Illinois

Chicago College of Medicine

Department of Nephrology

Chicago

IL

Disclosures

MF declares that he has no competing interests.

Junaid Masood, MBBS, FRCS (Eng), MSc (Urol), FRCS (Urol)

Consultant Urological Surgeon

Bart's and The London NHS Trust

London

UK

Disclosures

JM declares that he has no competing interests.

Vinod Nargund, PhD, FRCS (Urol), FEBU

Consultant Urological Surgeon

Homerton University and Bartholomew's Hospitals

London

UK

Disclosures

VN declares that he has no competing interests.

Use of this content is subject to our disclaimer